Nathalie Adda
2020
In 2020, Nathalie Adda earned a total compensation of $1.8M as Senior Vice President, Chief Medical Officer at Enanta Pharmaceuticals, a 12% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $173,372 |
|---|---|
| Option Awards | $981,504 |
| Salary | $451,550 |
| Stock Awards | $187,821 |
| Other | $19,171 |
| Total | $1,813,418 |
Adda received $981.5K in option awards, accounting for 54% of the total pay in 2020.
Adda also received $173.4K in non-equity incentive plan, $451.6K in salary, $187.8K in stock awards and $19.2K in other compensation.
Rankings
In 2020, Nathalie Adda's compensation ranked 5,976th out of 13,090 executives tracked by ExecPay. In other words, Adda earned more than 54.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,976 out of 13,090 | 54th |
Division Manufacturing | 2,461 out of 5,617 | 56th |
Major group Chemicals And Allied Products | 982 out of 2,248 | 56th |
Industry group Drugs | 850 out of 1,948 | 56th |
Industry Pharmaceutical Preparations | 632 out of 1,453 | 57th |
Pay ratio
| Nathalie Adda's Pay | $1,813,418 |
|---|---|
| Median Employee's Pay | $232,629 |
| Pay Ratio | 8to 1 |
In 2020, the annual total compensation of Nathalie Adda was $1,813,418.
The annual total compensation of the median employee at Enanta Pharmaceuticals was $232,629.
The ratio of Nathalie Adda's pay to the pay of median employee was therefore 8 to one.
Source: SEC filing on January 21, 2021.
Adda's colleagues
We found four more compensation records of executives who worked with Nathalie Adda at Enanta Pharmaceuticals in 2020.